Comparative plasma and tissue distribution of Sun Pharma’s generic doxorubicin HCl liposome injection versus Caelyx® (doxorubicin HCl liposome injection) in syngeneic fibrosarcoma-bearing BALB/c mice and Sprague–Dawley rats
Crossref DOI link: https://doi.org/10.1007/s00280-017-3278-9
Published Online: 2017-03-27
Published Print: 2017-05
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Burade, Vinod
Bhowmick, Subhas
Maiti, Kuntal
Zalawadia, Rishit
Jain, Deepak
Rajamannar, Thennati
Funding for this research was provided by:
Sun Pharmaceuticals Industries Ltd. (NA)
License valid from 2017-03-27